3-Phosphoglycerate dehydrogenase (Phgdh) is the initial step enzyme in the phosphorylated pathway of L-serine biosynthesis. We have previously revealed in the brain that Phgdh is preferentially expressed in glial cells, but not in neurons, and that glia-borne L-serine exerts strong neurotrophic actions to neuronal survive, differentiation, and development. To investigate whether such an L-serine-meditated intercellular relationship is constructed in peripheral organs and tissues, we examined the kidney, which is one of the organs with the highest expression of Phgdh mRNA in the body. We found that Phgdh was distributed highly in the renal papilla and inner layer of the outer zone and moderately in the cortex, whereas it was almost negative in the outer layer of the outer zone. This heterogeneous distribution was due to selective expression in distinct tubular segments, i.e., the Bowman's capsule, proximal tubule, and thin limbs of the Henle's loop. Interestingly, neutral amino acid transporter ASCT1, which preferentially transports alanine, serine, cysteine, and threonine, was selectively expressed in Phgdh-negative tubular segments, i.e., the distal tubule and collecting duct. Therefore, either Phgdh or ASCT1 is provided to each segment of renal tubules, suggesting that metabolic interplay mediated by L-serine biosynthesis and supply may exist in the kidney too. Takasaki et al. (3) 
Introduction
L-Serine is classified as a non-essential amino acid, since it can be synthesized sufficiently in human and animal bodies and the nitrogen balance is maintained without dietary intake (Snell, 1984) . This amino acid serves not only as a building block of proteins, but also as a precursor for other amino acids (L-cysteine, glycine, D-serine), phosphatidylserine, sphingolipids, and nucleotides. 3-Phosphoglycerol dehydrogenase (Phgdh or 3PGDH, EC 1.1.1.95) is the initial step enzyme in the phosphorylated pathway of L-serine biosynthesis, using 3-phosphoglycerate, an intermediate of the glycolytic pathway, as a starting material (Ichihara and Greenberg, 1957) . Phgdh is expressed in various organs and tissues, and is significantly upregulated in proliferating, differentiating, and neoplastic tissues (Davis and Fallon, 1970; Klomp et al., 2000; Yamasaki et al., 2001) . The fundamental importance of L-serine biosynthesis in vivo is appreciated from severe neurological symptoms of patients with inherited Phgdh deficiency, including congenital microcephaly, dysmyelination, intractable seizures, and psychomotor retardation (de Koning et al., 2003) . Furthermore, targeted disruption of the Phgdh gene in mice results in embryonic lethality at embryonic day 13.5 accompanied by striking defects and retardation of brain development (Yoshida et al., 2004) .
L-Serine plays as a glia-derived neurotrophic factor in the brain (Mitoma et al., 1998a; Furuya et al., 2000) . When astrocyte-conditioned medium or L-serine is supplied to cultured neurons, survival, dendritogenesis, synaptogenesis, and maturation of electrophysiological properties of the cultured neurons are greatly promoted, showing much greater potency than that Takasaki et al. (4) by neurotrophins (Furuya et al., 2000) . Why these experimental treatments manifest neurotrophic actions is now understood by the fact that Phgdh is expressed primarily by astrocytes, olfactory ensheathing glia, and Schwann cells, whereas neurons lack its expression (Furuya et al., 2000; Yamasaki et al., 2001; Yamashita et al., 2003) . Furthermore, these Phgdh-expressing glial cells also express neutral amino acid transporter ASCT1, which mediates obligatory exchange of alanine, serine, cysteine, and threonine . Based on these findings, we have concluded that L-serine biosynthesis in particular glial cells and its supply to nearby neurons constitute a novel neuron-glial relationship for normal brain development and function .
In the present study, we tested whether such an intercellular relationship based on the L-serine metabolism is built up in peripheral organs and tissues as well. For this purpose, we selected the kidney, because this is one of the organs with the highest expression of Phgdh mRNA (Achouri et al., 1997; Klomp et al., 2000) . Here we show that, similarly to the case in the brain, cellular expression of Phgdh is not ubiquitous but rather preferential to particular tubular segments. Unlike the case in the brain, Phgdh and ASCT1 are expressed in distinct tubular segments.
MATERIALS AND METHODS
Animals and section preparation. C57BL/6J mice at the adult stage (2-4 months of age) were used in the present study. Under deep pentobarbital anesthesia Takasaki et al. (5) (100 mg/kg of body weight, i.p.), the kidney for in situ hybridization was freshly obtained and frozen immediately with powdered dry ice. Frozen sections were prepared on a cryostat (20 μm in thickness; CM1900; Leica, Nussloch, Germany), mounted on silane-coated glass slides (Muto-Glass, Tokyo, Japan) and air-dried. For light microscopic immunohistochemistry, anesthetized mice were fixed transcardially with 4% paraformaldehyde in 0.1M sodium phosphate buffer (PB, pH 7.2), and processed for paraffin sectioning with a sliding microtome (4 μm; SM2000R, Leica) or for cryostat sections (50 μm; CM1900, Leica washing, and autoradiography to X-ray films, as reported previously (Yamasaki et al., 2001) . After confirming the same pattern of hybridization by individual Takasaki et al. (6) probes, three probes were mixed in order to raise the gain of signals. Photographs were taken by a light microscope (AX-70; Olympus Optical, Tokyo, Japan) equipped with a digital camera (DP70; Olympus Optical) or by a confocal laser scanning microscope (FV1000; Olympus Optical). We tested the Takasaki et al. (7) specificity of immunohistochemistry by blank labeling when the primary antibody was omitted.
Immunohistochemistry
For silver-enhanced immunogold labeling, microslicer sections were incubated successively with 5% bovine serum albumin in PBS containing 0.002% saponin for 30 min, rabbit anti-Phgdh antibody (1 μg/ml) overnight, and anti-rabbit IgG conjugated to 1.4 nm gold particles (1:200; Nanoprobes; Stony Brook, NY) overnight. Following postfixation with 1% glutaraldehyde in PB for 30 min and silver enhancement (HQ Silver Kit, Nanoprobes), sections were osmificated with 1% osmium tetroxide for 1.5 h and stained with 1% uranyl acetate for 30min. All sections were dehydrated using graded alcohols and embedded in Epon 812. Ultrathin sections were prepared with an ULTRACUT ultramicrotome (Leica, Wien, Austria), and photographs were taken with an H7100 electron microscope (Hitachi, Tokyo, Japan).
Western blot analysis. The kidney was homogenized using a Potter homogenizer with 15 strokes at 1000rpm in 10 volumes of ice-cold homogenizer buffer containing 0.32M sucrose, 1mM EDTA, 0.4mM EGTA, 10mM Tris-HCl (pH7.2), and 0.4mM phenylmethylsulfonyl fluoride. The protein concentration was determined by the Lowry's method. The homogenates were denatured by 50mM(+)-dithiothreitol at 65 ˚C for 15min. Proteins (15 μg/lane) were separated by SDS-polyacrylamide gel electrophoresis, and electroblotted onto nitrocellulose membranes (BioTraceNT; Pall Gelman Laboratory, Ann Arbor, MI, USA). After blocking with 5% skimmed milk for 30 min, membranes were incubated for 2 h with Phgdh antibody (1 μg/ml). Tris-buffered saline, pH7.5, containing 0.1% Triton X-100 was used for antibody diluent and washing buffer.
Takasaki et al. (8)
Immunoreaction was visualized with the ECL chemiluminescence detection system (Amersham Biosciences).
RESULTS

Phgdh mRNA expression in adult kidney
By in situ hybridization with 33 P-labeled antisense probes, expression of Phgdh mRNA was examined in the adult mouse kidney (Fig. 1) . Prominent expression was detected in the renal papilla (Fig. 1A) . In addition, clusters of low signals were sparsely distributed in the renal cortex and in the inner layer of the outer zone, whereas its outer layer lacked the signals. The specificity of hybridizing signals were tested by control hybridization, in which signals disappeared almost completely when hybridization was carried out in the presence of an excess amount of cold (unlabeled) probes (Fig. 1B) .
Specificity of Phgdh antibody and immunohistochemistry
The specificity of Phgdh antibody was tested by immunoblot (Fig. 2) . A single protein band at 60 kDa was detected in homogenates prepared from the kidney (Fig. 2, right) . The size of Phgdh in the kidney was similar to that in the brain (Fig. 2, left) . Tissue contents of Phgdh was higher in the kidney than in the brain.
Immunoperoxidase staining revealed distinct distribution of Phgdh in the adult kidney (Fig. 3) . Phgdh was detected intensely in small-calibered renal Takasaki et al. (9) tubules running through the renal papilla and inner layer of the outer zone (Fig.   3A , D-F), moderately in the Bowman's capsule (Fig. 3B) , and weakly in certain renal tubules of the cortex (asterisk in Fig. 3B ). Immunolabeling was low or negative in the outer layer of the outer zone (Fig. 3A, C) . Thus, general distribution of Phgdh immunoreactivity was essentially the same as that of Phgdh mRNA, suggesting the specificity of immunohistochemistry. This was further supported by the lack of immunostaining when Phgdh antibody was replaced with normal rabbit serum (Fig. 3G, H) .
Phgdh is expressed in Bowman's capsule, proximal tubules, and thin limb of Henle's loop
By multiple immunofluorescence labeling, expression of Phgdh in renal tubular segments was determined using segment-specific molecular markers (Fig. 4) .
Aquaporin-1 (AQP1) is a maker for the proximal tubule and thin descending limb of the Henle's loop (Agre, 2000) . Phgdh was weakly detected in AQP1-positive proximal tubules withinin the cortex (arrows in Fig. 4A, B) , and strongly in AQP1-positive thin-walled, small-calibered tubules, i.e., the thin descending limb of the Henle's loop (arrows in Fig. 4C, D) . Double immunostaining for chloride channel K (CLC-K), a marker for the thin ascending limb of the Henle's loop (Vandewalle, et al., 1997; Yoshikawa et al., 1999) , demonstrated co-expression of Phgdh in this segment (arrows in Fig. 4E, F) . In double immunofluorescence for calbindin, a marker of the distal convoluted tubule and connecting segment (Taylor et al., 1982) , and for aquaporin-2 (AQP2), a marker for the collecting duct (Nielsen et al., 1993) , Phgdh was not Takasaki et al. (10) detected in calbindin-positive distal convoluted tubules and connecting segment (arrowheads in Fig. 4G ) or in AQP2-positive collecting ducts (arrowheads in Fig.   4H ). Therefore, these results from light microscopic and confocal laser scanning microscopic immunohistochemistry indicate that Phgdh is expressed in the Bowman's capsule, proximal tubule, and thin descending and ascending limbs of the Henle's loop.
This was confirmed by immunoelectron microscopy (Fig. 5) . By the silver enhanced immunogold method, metal particles were deposited in the cytoplasm of squamous epithelial cells of the Bowman's capsule (Fig. 5A) , and in that of epithelial cells of the proximal tubule (Fig. 5B) . Among tubular segments, the heaviest labeling was observed in the cytoplasm of thin-walled, small-calibered epithelial cells of the Henle's loop (Fig. 5C ). In contrast, labeling was very low or at the background level in epithelial cells of the distal tubule and collecting duct (Fig. 5D , E), consistent with light microscopic and confocal laser scanning microscopic observations (Figs. 3, 4 ).
Phgdh and ASCT1 are expressed in distinct tubular segments
Because L-serine is utilized for syntheses of various biomolecules, including other amino acids, proteins, membrane lipids, and nucleotides , renal cells lacking or low in Phgdh should somehow take in this amino acid for their activities, function, proliferation, and survival. To test this possibility, we finally examined the distribution of ASCT1 (Fig. 6) , which is one of the system ASC or alanine/serine/cysteine-preferring transporters (Arriza et al., 1993; Shafqat et al., 1993) . Interestingly, we found non-overlapping Takasaki et al. (11) patterns of Phgdh and ASCT1 expressions in the renal cortex (Fig. 6A , B) and medulla ( Fig. 6G, H) . In the cortex, ASCT1 was distributed in calbindin-positive distal convoluted tubules and/or connecting segment (arrows in Fig. 6C, D) , but not in AQP1-positive proximal tubules (arrowheads in Fig. 6E, F) . In the medulla, ASCT1 was detected in AQP2-positive collecting ducts (arrows in Fig. 6I, J) , but not in AQP1-positive thin descending limb (arrowheads in Fig. 6K ) or CLC-K-positive thin ascending limb (arrowheads in Fig. 6L ) of the Henle's loop.
Therefore, Phgdh and ASCT1 display complementary expression in the kidney.
Furthermore, we note different subcellular distribution of ASCT1 between the two immunopositive tubules. ASCT1 was detected widely in the distal convoluted tubule, irrespective of the apical and basal sides (Fig. 6A-D) . In contrast, ASCT1 was preferentially distributed along the basolateral surface of the collecting duct (Fig. 6I-L) .
Discussion
In the present study, we analyzed L-serine biosynthetic enzyme Phgdh in the adult mouse kidney, since this organ is known to express its mRNA at high levels (Achouri et al., 1997; Cho et al., 2000; Klomp et al., 2000) . We detected a single protein band in the kidney, which is much higher in levels than that in the brain (Fig. 2) . Even in the kidney with high tissue contents, cellular expression of Phgdh in the kidney was not ubiquitous, but rather specific to distinct tubular segments, i.e., the Bowman's capsule, proximal tubule, and thin limb of the Henle's loop. Together with our previous studies in nervous tissues (Furuya et Takasaki et al. (12) al., 2000; Yamasaki et al., 2001; Yamashita et al., 2003) , the present result eventually highlights that, although the phosphorylated pathway of L-serine biosynthesis has been though to be a widely distributed cytosolic pathway (Ichihara and Greenberg, 1957; Snell, 1984) , the ability of L-serine biosynthesis is provided to particular cell types within given tissues and organs. In this regard, the fact that levels of Phgdh mRNA are highly variable from tissue to tissue (Klomp et al., 2000) appears noteworthy, because this suggests that Phgdh is not a kind of housekeeping molecules and also because this could reflect cell type-specific expression in other tissues.
Why is Phgdh expression confined to distinct tubular segments?
L-Serine is readily interconvertible to glycine, which is an important material as carbon and nitrogen donors for the purine and heme syntheses. In addition, L-serine is indispensable for the synthesis of phosphatidylserine and sphingolipids, i.e., basic components of the cell membrane and integral components of cell membrane microdomains, known as rafts and caveolae (Furuya et al., 1995 (Furuya et al., , 1998 Mitoma et al., 1998b; Yamashita et al., 1999; dos Santos Fagundes et al., 2001) . Therefore, one possibility is that tubular segments expressing Phgdh might be highly active in syntheses of proteins, nucleotides, heme, and cell membrane and thereby have especially high demands for L-serine than other segments lacking or low in Phgdh. Another possibility is that the different ability of L-serine synthesis would reflect different vulnerability to energy loss among renal cells, because L-serine is synthesized by depriving an intermediate of the glycolytic pathway, 3-phosphoglycerate. In the brain, it has been proposed that the lack of Phgdh in neurons would be Takasaki et al. (13) beneficial for neurons themselves, because the availability of glia-borne L-serine may save their own glycolytic intermediates for preferential use in energy production, supporting neuronal survival and function (Yamasaki et al., 2001) . If this is the case in the kidney as well, tubular segments expressing Phgdh may play a role in the supply of L-serine to neighboring tubular segments negative in Phgdh expression.
In the present study, we found that expression of neutral amino acid transporter ASCT1 was also segmental within the kidney, i.e., the distal 
